BioVersys: First ever patient dosed with alpibectir-ethionamide in combination with first-line TB drugs in a 14-day phase 2 clinical trial
Tuberculosis remains the largest infectious disease killer in the world and is far from being eradicated. Our partnership with GSK,…
